Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug:192:2.
doi: 10.1016/j.thromres.2020.05.001. Epub 2020 May 5.

Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid

U Zachariah  1 , S C Nair  2 , A Goel  1 , K A Balasubramanian  3 , I Mackie  4 , E Elias  5 , C E Eapen  6
Affiliations
Comment

Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid

U Zachariah et al. Thromb Res. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Comment on

References

    1. Escher R., Breakey N., Lämmle B. Severe COVID-19 infection associated with endothelial activation [published online ahead of print, 2020 Apr 15] Thromb. Res. 2020;190:62. doi: 10.1016/j.thromres.2020.04.014. - DOI - PMC - PubMed
    1. Thachil J., Tang N., Gando S. ISTH interim guidance on recognition and management of coagulopathy in COVID-19 [published online ahead of print, 2020 Mar 25] J. Thromb. Haemost. 2020 doi: 10.1111/jth.14810. (doi:https://doi.org/10.1111/jth.14810) - DOI - PMC - PubMed
    1. Sardar D., Mathews N., Mammen J. Rodenticidal hepatotoxicity: raised plasma Von Willebrand factor levels predict in-hospital survival and preliminary report of the outcome of Von Willebrand factor reducing management protocol. Indian J. Gastroenterol. 2019;38(6):527–533. - PubMed
    1. Prasanna K.S., Goel A., Amirtharaj G.J. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure. Indian J. Gastroenterol. 2016;35(6):432–440. - PubMed
    1. Goel A., Nair S.C., Zachariah U. Targetting raised von Willebrand factor levels in liver diseases: opening up newer therapeutic avenues. EMJ Hepatol. 2020 doi: 10.33590/hepatol/20-00051. (DOI/10.33590/hepatol/20-00051) - DOI